| scholarly article | Q13442814 |
| P2093 | author name string | Martin Markowitz | |
| Nicole Prada | |||
| Hiroshi Mohri | |||
| P2860 | cites work | The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens | Q22242262 |
| HIV: cell binding and entry | Q27008983 | ||
| MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods | Q27860929 | ||
| Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin | Q28264707 | ||
| Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites | Q28379086 | ||
| Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors | Q28379411 | ||
| N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance | Q28471689 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 | ||
| Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. | Q29622903 | ||
| Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication | Q30305454 | ||
| A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression | Q33604871 | ||
| Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry | Q33788743 | ||
| Transcriptional and posttranscriptional regulation of HIV-1 gene expression | Q34030804 | ||
| A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences | Q34372546 | ||
| Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report | Q34405065 | ||
| Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay | Q34434646 | ||
| Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing | Q34742873 | ||
| Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection | Q35104695 | ||
| The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions | Q35784897 | ||
| Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. | Q35905947 | ||
| The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques | Q36401769 | ||
| Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule | Q36697652 | ||
| Web resources for HIV type 1 genotypic-resistance test interpretation | Q36899999 | ||
| Clinical significance of human immunodeficiency virus type 1 replication fitness | Q36969857 | ||
| In vitro characterization of multidrug-resistant HIV-1 isolates from a recently infected patient associated with dual tropism and rapid disease progression | Q37051661 | ||
| The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env. | Q37410623 | ||
| HIV-1 assembly, budding, and maturation | Q38023864 | ||
| Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. | Q39550343 | ||
| Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro | Q39578289 | ||
| Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir | Q39601382 | ||
| Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity | Q39621109 | ||
| Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population | Q39642550 | ||
| Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant | Q41040160 | ||
| Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge | Q48073666 | ||
| Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients. | Q53570987 | ||
| Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy | Q73271748 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 487-494 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant | |
| P478 | volume | 68 |
| Q40548483 | High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia | cites work | P2860 |
Search more.